The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy.

Tadzic R, Mihalj M, Vcev A, Ennen J, Tadzic A, Drenjancevic I

Open source

DOI
10.1159/000350064
Published
2013
Container
Kidney & blood pressure research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000350064,
  title = {The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy.},
  author = {Tadzic R and Mihalj M and Vcev A and Ennen J and Tadzic A and Drenjancevic I},
  year = {2013},
  journal = {Kidney \& blood pressure research},
  doi = {10.1159/000350064},
  url = {https://doi.org/10.1159/000350064}
}

RIS

TY  - JOUR
TI  - The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy.
AU  - Tadzic R
AU  - Mihalj M
AU  - Vcev A
AU  - Ennen J
AU  - Tadzic A
AU  - Drenjancevic I
PY  - 2013
JO  - Kidney & blood pressure research
DO  - 10.1159/000350064
UR  - https://doi.org/10.1159/000350064
ER  - 

APA

R, T., M, M., A, V., J, E., A, T., & I, D. (2013). The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy.. Kidney & blood pressure research. https://doi.org/10.1159/000350064

Source records